Article
Astellas wagers $425M-plus to buy a shot at hatching a 'neural dust' breakthrough in bioelectronics
Rating:
0.0
Views:
99
Likes:
1
Library:
1
Over the past 2 years Astellas has been moving closer and closer to a Berkeley startup called iota Biosciences. First they invested in the developer of ultra-tiny, dust sized implantable medical devices in 2018. Then they partnered a year ago. And today they've moved in to buy the whole thing.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value